Leg Injuries: Clinical Trials

66 trials for Leg Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

66 completed. 66 Phase 3, 10 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 366Completed 66
Phase 210Completed 10

Follow Leg Injuries: new trials by email Literature Review of Leg Injuries trials Research Report on Leg Injuries

Trials (filtered) newest first · largest first

All 66 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Counterpain PXM Versus Diclofenac Versus Piroxicam
Piroxicam plus Counterirritant (brand name Counterpain® PXM)., Diclofenac Sodium 10 mg (Brand Name Hotin® DCL), Piroxicam 0.5% (Brand name Pirofel® gel) - Ankle Sprain, Back Pain
Phase 3CompletedTaisho Pharmaceutical Indonesia1802025-11-042026-03-16
Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains.
Esflurbiprofen Topical System (EFTS), Placebo Patch - Ankle Sprains
Phase 3CompletedTeikoku Seiyaku Co., Ltd.692025-03-312025-11-26
Effectiveness Comparison Between Continuous Cryotherapy and Ice Pack Therapy After Anterior Cruciate Ligament Reconstruction Surgery
Continuous compression cryotherapy, Conventional ice treatment - Postoperative Pain, Acute, Anterior Cruciate Ligament Injuries
Phase 2 / Phase 3CompletedUniversity Medical Center Ho Chi Minh City (UMC)722023-06-012024-10-08
Feasibility of a RCT That Compares Immediate Versus Optional Delayed Surgical Repair After ACL Injury
Immediate anterior cruciate ligament reconstruction, Rehabilitation, Optional delayed anterior cruciate ligament reconstruction - Anterior Cruciate Ligament Injuries
Phase 3CompletedUniversitaire Ziekenhuizen KU Leuven292020-09-152023-11-15
Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population
Tranexamic Acid Injectable Solution, Placebo - Hip Fractures
Phase 3CompletedLancaster General Hospital2832020-02-012024-10-10
Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study
Diclofenac diethylamine 2.32% gel, Diclofenac diethylamine 1.16% gel, Placebo - Pain
Phase 3CompletedGlaxoSmithKline3132019-10-242022-04-12
Traumatologic Acute Pain Management With Fentanyl Transdermal Therapeutic System (TTS)
Fentanyl Transdermal System, Placebo - Hip Fractures (ICD-10 72.01-72.2)
Phase 3CompletedMedical University of Graz1452019-06-302020-07-22
Can Continuous Non-invasive Monitoring Improve Stability of Intraoperative Blood Pressure - A Feasibility Study.
Continuous non-invasive blood pressure monitoring - Hip Fractures, Hypotension on Induction
Phase 3CompletedUniversity Hospital Birmingham NHS Foundation Trust302019-06-132022-05-18
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery
Ketorolac, Oxycodone-Acetaminophen - ACL Injury, Postoperative Pain
Phase 3CompletedUniversity Hospitals Cleveland Medical Center492019-05-212021-12-21
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery
Ketorolac, Oxycodone-Acetaminophen - Meniscus Tear, Tibial, Pain, Postoperative
Phase 3CompletedUniversity Hospitals Cleveland Medical Center482019-04-232022-03-03
Starting a Testosterone and Exercise Program After Hip Injury
Testosterone, Placebo gel, Supervised exercise training - Hip Fracture, Frailty
Phase 3CompletedWashington University School of Medicine1292019-03-052025-02-04
Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction
Celecoxib, Hydrocodone-Acetaminophen, Ketorolac - Anterior Cruciate Ligament Injury
Phase 2 / Phase 3CompletedHenry Ford Health System902019-01-222026-03-19
Objective Results of Anterior Cruciate Ligament Reconstruction With and Without Internal Suture Augmentation Technique
all- inside anterior cruciate ligament reconstruction - Anterior Cruciate Ligament Injuries
Phase 2 / Phase 3CompletedAin Shams University382018-09-012021-06-02
Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)
PLX-PAD, Placebo - Hip Fracture
Phase 3CompletedPluristem Ltd.2402018-07-262023-09-28
Clinical Application of Mg Based Biodegradable Material for Fracture Fixation in the Adult Skeleton
BRI.MAG 2 - Fracture of Medial Malleolus
Phase 2 / Phase 3CompletedMedical University of Graz202018-07-092023-01-31
TRAUMED - a Clinical Trial in Acute Ankle Sprain
Traumeel®, Diclofenac sodium gel 1%, Placebo - Ankle Sprain
Phase 3CompletedBiologische Heilmittel Heel GmbH8092018-02-262024-01-31
Intra-articular Dexmedetomidine Versus Neostigmine After Knee Arthroscopy (a Comparative Study)
dexamedetomidine, neostigmine - Knee Injuries
Phase 2 / Phase 3CompletedAssiut University1002017-08-012018-01-11
Topical Tranexamic Acid (TXA) in Hip Fractures
Tranexamic Acid, Saline Wash - Hip Fracture, Anemia
Phase 3CompletedSault Area Hospital652016-11-012019-08-19
Clinical Outcomes of ACL Reconstruction Augmented by an Injectable Osteoconductive/Osteoinductive Compound
OOC - ACL Injury
Phase 3CompletedUniversity of Miami262016-10-242021-09-05
Post Approval Study to Evaluate the Effectiveness and Safety of Cartiva Implant in the Treatment of OA of the Great Toe
Cartiva - Osteoarthritis of First Metatarsalphalangeal Joint
Phase 3CompletedCartiva, Inc.1352016-10-012019-03-22

Showing 20 of 66. Sign in to see all of them.

Narrower conditions

Hip Fractures (26)  ·  Ankle Injuries (17)  ·  Anterior Cruciate Ligament Injuries (7)  ·  Pain (6)  ·  Knee Injuries (5)  ·  Soft Tissue Injuries (5)  ·  Osteoporosis (4)  ·  Pain, Postoperative (4)  ·  Ankle Fractures (3)  ·  Osteoarthritis (3)  ·  Anemia (2)  ·  Bone Diseases, Metabolic (2)  ·  Femoral Neck Fractures (2)  ·  Fractures, Bone (2)  ·  Hallux Limitus (2)

Broader conditions

Wounds and Injuries (64)  ·  Fractures, Bone (31)  ·  Hip Injuries (28)  ·  Femoral Fractures (27)  ·  Pathological Conditions, Signs and Symptoms (17)  ·  Neurologic Manifestations (12)  ·  Signs and Symptoms (12)  ·  Pathologic Processes (11)  ·  Knee Injuries (8)  ·  Musculoskeletal Diseases (8)  ·  Bone Diseases (4)  ·  Joint Diseases (4)  ·  Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)

Interventions

Tranexamic Acid (4)  ·  Diclofenac (3)  ·  Ketorolac (3)  ·  oxycodone-acetaminophen (3)  ·  Acetaminophen (2)  ·  Alendronate (2)  ·  Bupivacaine (2)  ·  Celecoxib (2)  ·  Dexmedetomidine (2)  ·  Enoxaparin (2)  ·  OMS 103HP (2)  ·  Ropivacaine (2)  ·  Sodium Chloride (2)  ·  Teriparatide (2)  ·  Testosterone (2)

Sponsors

Novartis (3)  ·  Biologische Heilmittel Heel GmbH (2)  ·  Cartiva, Inc. (2)  ·  Chinese University of Hong Kong (2)  ·  Eli Lilly and Company (2)  ·  Hisamitsu Pharmaceutical Co., Inc. (2)  ·  Medical University of Graz (2)  ·  Omeros Corporation (2)  ·  Prince of Songkla University (2)  ·  Sanofi (2)  ·  University Hospitals Cleveland Medical Center (2)  ·  Washington University School of Medicine (2)  ·  Abbott Nutrition (1)  ·  Actavis Inc. (1)  ·  Ain Shams University (1)

Countries

United States (28)  ·  Canada (9)  ·  Germany (7)  ·  Spain (5)  ·  China (4)  ·  France (4)  ·  India (4)  ·  United Kingdom (4)  ·  Austria (3)  ·  Israel (3)  ·  Sweden (3)  ·  Turkey (Türkiye) (3)  ·  Australia (2)  ·  Belgium (2)  ·  Bulgaria (2)

Top investigators

Boonsin Tangtrakulwanich, MD.,Ph.D (2)  ·  Michael Karns, MD (2)  ·  Scott Houston (2)  ·  Ahmed A Khater, MD (1)  ·  Alexander G. Turpie (1)  ·  Anis Aribogan, Prof., MD (1)  ·  Anne C Voss, PhD (1)  ·  Carlos Gonzalez de Vega, MD (1)  ·  Cathleen S. Colon-Emeric, MD, MHSc (1)  ·  David Flanigan, MD (1)  ·  Donald W Morrish, MD, PhD (1)  ·  Ellen F Binder, MD (1)  ·  Ellen F. Binder, MD (1)

Results publications

PMID 15329580, PMID 16835255, PMID 17113683, PMID 17878149, PMID 17904460, PMID 18567675, PMID 18767928, PMID 19926634, PMID 20973952, PMID 21037195, PMID 21249332, PMID 22152181, PMID 22353604, PMID 22429800, PMID 22631877, PMID 23812596, PMID 23889885, PMID 24330470, PMID 24839241, PMID 25043629, PMID 26323728, PMID 26631990, PMID 27195774, PMID 27779431, PMID 29377866, PMID 33238043, PMID 34388107, PMID 34766330, PMID 35277406, PMID 36045358, PMID 36070134, PMID 36476466, PMID 36566202, PMID 38085188, PMID 40340976, PMID 40372752, PMID 40468690, PMID 40540943, PMID 41624165, PMID 41837612

NIH funding

2008 (1), 2009 (1), 2016 (1)